Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: Update of the MDACC series

Annals of Oncology

Volumn 11, Issue SUPPL. 1, 2000, Pages

  Lopez Guillermo A ^a,b,c   Cabanillas, F ^a   McLaughlin, P ^a   Smith, T ^a   Hagemeister, F ^a   Rodriguez M A ^a   Romaguera, J E ^a   Younes, A ^a   Sarris, A H ^a   Preti, H A ^a   Pugh, W ^a   Lee, M S ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

BCL 2; Follicular lymphoma; Minimal residual disease; PCR; Prognostic factors

Indexed keywords

BETA 2 MICROGLOBULIN; PROTEIN BCL 2;

ADULT; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; CANCER THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0342545911     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/11.suppl_1.S137     Document Type: Conference Paper

References (17)

1. Lister TA. The management of follicular lymphoma. Ann Oncol 1991; 2: 131-5.
2. Romaguera JE, McLaughlin P, North L et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: A risk model. J Clin Oncol 1991; 9: 762-9.
3. Yunis JJ, Oken MM, Kaplan ME et al. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 1982; 307: 1231-6.
4. Lee MS, Chang KS, Cabanillas F et al. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 1987; 237: 175-8.
5. Stetler-Stevenson M, Raffeld M, Cohen P, Cossman J. Detection of occult follicular lymphoma by specific DNA amplification. Blood 1988; 72: 1822-5.
6. Price CGA. Meerabux J, Murtagh S et al. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 1991; 9: 1527-32.
7. Finke J, Slanina J, Lange W, Dolken G. Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J Clin Oncol 1993; 11: 1668-73.
8. Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991; 325: 1525-33.
9. Lambrechts AC, Hupkes PE, Dorssers LCJ, van 't Veer MB. Clinical significance of t(14;18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol 1994; 12: 1541-6.
10. Gribben JG, Neuberg D, Freedman AS et al. Detection by polymerase chain reaction of residual cells with the BCL-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449-57.
11. Hardingham JE, Kotasek D, Sage RE et al. Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1995; 13: 1073-9.
12. López-Guillermo A, Cabanillas F, McLaughlin P et al. The clinical significance of molecular response in indolent follicular lymphomas. Blood 1998; 91: 2955-60.
13. McLaughlin P, Hagemeister FB, Swan F et al. Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: High remission rates and reversion to negative of peripheral blood BCL-2 rearrangement. Ann Oncol 1994; 5 (Suppl 2): S73-7.
14. Gribben JG, Nadler LM. Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction. In DeVita VT, Hellman S, Rosenberg SA (eds): Important Advances in Oncology 1994. Philadelphia: Lippincott 1994.
15. Moos M, Schulz R, Martin S et al. The remission status before and the PCR status after high-dose therapy with peripheral blood stem-cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphoma. Leukemia 1998; 12: 1971-6.
16. von Neuhoff N, Dreger P, Suttorrp M et al. Comparison of different strategies of molecular genetic monitoring following autologous stem-cell transplantation in patients with follicular lymphoma. BMT 1998; 22: 161-6.
17. Gribben JG, Neuberg D, Barber M et al. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 1994; 83: 3800-7.